Iris Grossman
Iris Grossman
Cofounder and CSO, GROSS Advantage
Verified email at grossmail.com - Homepage
Title
Cited by
Cited by
Year
General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised …
O Golubnitschaja, V Costigliola
EPMA Journal 3 (1), 1-53, 2012
2032012
Drug repurposing from the perspective of pharmaceutical companies
Y Cha, T Erez, IJ Reynolds, D Kumar, J Ross, G Koytiger, R Kusko, ...
British journal of pharmacology 175 (2), 168-180, 2018
1302018
Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis
AC Need, RSE Keefe, D Ge, I Grossman, S Dickson, JP McEvoy, ...
European Journal of Human Genetics 17 (7), 946-957, 2009
1022009
Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers
I Grossman, N Avidan, C Singer, D Goldstaub, L Hayardeny, E Eyal, ...
Pharmacogenetics and genomics 17 (8), 657-666, 2007
832007
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor
J Kaye, V Piryatinsky, T Birnberg, T Hingaly, E Raymond, R Kashi, ...
Proceedings of the National Academy of Sciences 113 (41), E6145-E6152, 2016
752016
Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).
DB Matchar, ME Thakur, I Grossman, DC McCrory, LA Orlando, ...
Evidence report/technology assessment, 1-77, 2007
752007
The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease
D Ryskamp, J Wu, M Geva, R Kusko, I Grossman, M Hayden, ...
Neurobiology of disease 97, 46-59, 2017
702017
Using genetics to enable studies on the prevention of Alzheimer's disease
DG Crenshaw, WK Gottschalk, MW Lutz, I Grossman, AM Saunders, ...
Clinical Pharmacology & Therapeutics 93 (2), 177-185, 2013
672013
Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes
O Makeeva, V Stepanov, V Puzyrev, DB Goldstein, I Grossman
Future Medicine Ltd 9 (7), 847-868, 2008
672008
Characterization of the poly-T variant in the TOMM40 gene in diverse populations
C Linnertz, AM Saunders, MW Lutz, DM Crenshaw, I Grossman, DK Burns, ...
PloS one 7 (2), e30994, 2012
622012
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
M Geva, R Kusko, H Soares, KD Fowler, T Birnberg, S Barash, ...
Human molecular genetics 25 (18), 3975-3987, 2016
592016
TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial
AD Roses, MW Lutz, DG Crenshaw, I Grossman, AM Saunders, ...
Alzheimer's & Dementia 9 (2), 132-136, 2013
592013
Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors
M Thakur, I Grossman, DC McCrory, LA Orlando, DC Steffens, KE Cline, ...
Genetics in Medicine 9 (12), 826-835, 2007
552007
Routine pharmacogenetic testing in clinical practice: dream or reality?
I Grossman
Future Medicine Ltd 8 (10), 1449-1459, 2007
492007
Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study
I Grossman, PF Sullivan, N Walley, Y Liu, JR Dawson, C Gumbs, ...
Genetics in medicine 10 (10), 720-729, 2008
462008
Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: a pharmacogenetic study
M Masellis, S Collinson, N Freeman, M Tampakeras, J Levy, A Tchelet, ...
Brain 139 (7), 2050-2062, 2016
432016
Alzheimer’s disease: diagnostics, prognostics and the road to prevention
I Grossman, MW Lutz, DG Crenshaw, AM Saunders, DK Burns, AD Roses
EPMA Journal 1 (2), 293-303, 2010
402010
Bio-markers of disease activity and response to therapy in multiple sclerosis
A Miller, L Glass-Marmor, M Abraham, I Grossman, S Shapiro, Y Galboiz
Clinical neurology and neurosurgery 106 (3), 249-254, 2004
352004
Markers associated with the therapeutic efficacy of glatiramer acetate
D Lancet, J Beckmann, N Avidan, E Ben-Asher, D Goldstaub, ...
US Patent App. 11/409,590, 2006
302006
ADME pharmacogenetics: current practices and future outlook
I Grossman
Expert opinion on drug metabolism & toxicology 5 (5), 449-462, 2009
282009
The system can't perform the operation now. Try again later.
Articles 1–20